Key TakeawaysBFLY shares surged 22% on Tuesday, closing at $9.93 per share.Needham initiated coverage with a Buy recommendation and $10 price target.Analysts emphasized the company’s cMUT chip-based ultrasound platform and Embedded division.The company posted record Q2 revenue reaching $32.6 million.Shares maintained momentum near the $10 level in premarket trading Wednesday.Butterfly Network (BFLY) shares experienced a significant 22% surge on Tuesday following Needham’s initiation of coverage with a Buy recommendation and a $10 price objective. The stock closed at $9.93, representing a substantial increase from the prior session’s close of $8.14.Butterfly Network, Inc., BFLYThe upward momentum extended into Wednesday’s premarket session, though with reduced intensity. BFLY traded near $9.98, representing approximately 0.5% gains, after touching an intraday high of $10.05.Needham’s David Saxon emphasized the company’s proprietary cMUT semiconductor-based ultrasound platform as central to his optimistic outlook. The investment firm believes this technology platform could enable medical applications extending beyond Butterfly‘s core handheld ultrasound device market.Expansion Opportunities Through Embedded TechnologyNeedham drew attention to Butterfly Embedded, a business segment enabling third-party companies to integrate Butterfly’s ultrasound-on-chip technology into their own medical devices. Saxon views this division as a strategic avenue for market expansion without requiring Butterfly to independently develop every end product.The analyst further noted potential catalysts from the company’s core ultrasound business. According to Needham, several product launches and new applications scheduled for the near term could drive additional growth.Butterfly’s partnership ecosystem has attracted considerable investor interest. The company recently secured a multi-year licensing deal with Merge Labs, providing its ultrasound technology for developing minimally invasive brain-computer interface solutions.Additionally, Butterfly collaborates with Midjourney Medical on a comprehensive full-body ultrasound imaging platform utilizing Butterfly’s technology. Needham considers these Embedded partnerships fundamental to the investment thesis.Needham’s $10 price objective represents only modest upside from Tuesday’s closing level of $9.93. According to FactSet data referenced by MT Newswires, the consensus analyst target stands at approximately $10.50.Strong Financial Results Bolster Investment CaseButterfly’s latest quarterly results add supporting evidence for the share price rally. The company delivered second-quarter revenue of $32.6 million, representing 39% growth compared to $23.4 million in the year-ago period.This distinction matters because certain reports mistakenly cited $15.72 million as complete second-quarter revenue. That $15.72 million represented product revenue exclusively, while software and additional services generated another $16.89 million.Gross margin expanded to 71.4% from 63.7% year-over-year, benefiting from higher-margin Embedded licensing revenue streams. The company also reduced its adjusted EBITDA loss to $1.4 million from $6.2 million previously.Management upgraded its 2026 revenue guidance to a range of $119 million to $123 million while projecting an adjusted EBITDA loss between $19 million and $23 million. Butterfly reported cash and cash equivalents of $124.7 million at the end of June.Primary investment risks include valuation considerations, ongoing operating losses, and uncertainty around commercial scalability of newer Embedded products. Needham also noted competitive pressure from established medical imaging corporations and the likelihood of sustained capital investment requirements for next-generation technology development.Currently, Needham’s fresh Buy rating appears to have catalyzed Tuesday’s substantial 22% advance. Recent trading indicates BFLY maintaining support around the $10 threshold Wednesday morning following its most significant single-day gain in recent months.The post Butterfly Network (BFLY) Stock Surges 22% Following Needham’s Bullish Initiation appeared first on Blockonomi.